Cas 749844-54-0,(S) 8-(3-aminopyrrolidin-1-yl)-7-(2-bromobenzyl)-1,3-dimethyl-3,7-dihydropurine-2,6-dione

749844-54-0

Post Buying Request

Basic information

Product Name: (S) 8-(3-aminopyrrolidin-1-yl)-7-(2-bromobenzyl)-1,3-dimethyl-3,7-dihydropurine-2,6-dione
Synonyms: (S) 8-(3-aminopyrrolidin-1-yl)-7-(2-bromobenzyl)-1,3-dimethyl-3,7-dihydropurine-2,6-dione
CAS NO:749844-54-0
Molecular Formula:
Molecular Weight: 433.308
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (S) 8-(3-aminopyrrolidin-1-yl)-7-(2-bromobenzyl)-1,3-dimethyl-3,7-dihydropurine-2,6-dione(CAS DataBase Reference)
NIST Chemistry Reference: (S) 8-(3-aminopyrrolidin-1-yl)-7-(2-bromobenzyl)-1,3-dimethyl-3,7-dihydropurine-2,6-dione(749844-54-0)
EPA Substance Registry System: (S) 8-(3-aminopyrrolidin-1-yl)-7-(2-bromobenzyl)-1,3-dimethyl-3,7-dihydropurine-2,6-dione(749844-54-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 749844-54-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

749844-54-0 Suppliers

Recommended suppliers

749844-54-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 749844-54-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,4,9,8,4 and 4 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 749844-54:
(8*7)+(7*4)+(6*9)+(5*8)+(4*4)+(3*4)+(2*5)+(1*4)=220
220 % 10 = 0
So 749844-54-0 is a valid CAS Registry Number.

749844-54-0Upstream product

749844-54-0Downstream Products

749844-54-0Relevant academic research and scientific papers

Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states

-

Page 25, (2010/02/06)

The present invention is related to a method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states comprising administering inhibitors of the enzymes NEP and DPP-IV to individuals suffering from one or m

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 749844-54-0